Our findings reveal that SPINK1 expression was predominantly observed in a subgroup of cancers that expressed TFF3 (n = 6/6, p-value 0.013 highlighting the potential significance of assessing both TFF3 and SPINK1 statuses in order to stratify the risk of PCa patients. Here, SPINK1 is linked to posterior cortical atrophy.